track name="HDAC8 (@ Blood) 500" url="http://chip-atlas.org/view?id=$$" gffTags="on"
chr1 38077359 38077409 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 943 . 38077359 38077409 255,58,0
chr10 42428720 42428758 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 574 . 42428720 42428758 75,255,0
chr10 119941178 119941238 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 675 . 119941178 119941238 178,255,0
chr11 10529453 10529494 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 519 . 10529453 10529494 19,255,0
chr11 10530449 10530537 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 519 . 10530449 10530537 19,255,0
chr11 10530772 10530829 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 519 . 10530772 10530829 19,255,0
chr11 10530906 10530947 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 520 . 10530906 10530947 20,255,0
chr11 10531050 10531093 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 520 . 10531050 10531093 20,255,0
chr11 10531159 10531265 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 509 . 10531159 10531265 9,255,0
chr11 54833654 54833690 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 517 . 54833654 54833690 17,255,0
chr11 62609120 62609156 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 506 . 62609120 62609156 6,255,0
chr11 122874323 122874376 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 1000 . 122874323 122874376 255,0,0
chr12 34853885 34853921 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 527 . 34853885 34853921 27,255,0
chr12 41757454 41757515 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 1000 . 41757454 41757515 255,0,0
chr12 132061413 132061681 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 555 . 132061413 132061681 56,255,0
chr12 132061755 132061814 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 529 . 132061755 132061814 29,255,0
chr13 110076484 110076677 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 849 . 110076484 110076677 255,154,0
chr14 32954257 32954312 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 936 . 32954257 32954312 255,65,0
chr16 35239646 35239694 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 575 . 35239646 35239694 76,255,0
chr17 51183686 51183734 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 911 . 51183686 51183734 255,90,0
chr18 2842278 2842315 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 593 . 2842278 2842315 94,255,0
chr18 44126457 44126496 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 524 . 44126457 44126496 24,255,0
chr18 45379653 45379708 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 1000 . 45379653 45379708 255,0,0
chr18 50319143 50319225 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 754 . 50319143 50319225 255,250,0
chr19 59118916 59118960 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 570 . 59118916 59118960 71,255,0
chr2 49456911 49456957 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 842 . 49456911 49456957 255,161,0
chr2 88124420 88124488 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 872 . 88124420 88124488 255,130,0
chr2 149639305 149639408 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 866 . 149639305 149639408 255,136,0
chr2 182140535 182140572 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 537 . 182140535 182140572 37,255,0
chr21 10492894 10492955 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 1000 . 10492894 10492955 255,0,0
chr21 48119798 48119853 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 589 . 48119798 48119853 90,255,0
chr3 96336140 96336177 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 613 . 96336140 96336177 115,255,0
chr3 96336243 96336289 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 684 . 96336243 96336289 187,255,0
chr3 96336624 96336666 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 671 . 96336624 96336666 174,255,0
chr3 96336765 96336835 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 730 . 96336765 96336835 234,255,0
chr3 196625627 196625764 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 826 . 196625627 196625764 255,177,0
chr4 163342607 163342643 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 534 . 163342607 163342643 34,255,0
chr4 190802585 190802621 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 501 . 190802585 190802621 1,255,0
chr5 46391688 46391724 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 542 . 46391688 46391724 42,255,0
chr5 79946611 79946669 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 535 . 79946611 79946669 35,255,0
chr5 79946714 79946750 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 524 . 79946714 79946750 24,255,0
chr5 79947020 79947066 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 546 . 79947020 79947066 46,255,0
chr5 79947273 79947395 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 544 . 79947273 79947395 44,255,0
chr5 93905194 93905232 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 580 . 93905194 93905232 81,255,0
chr5 99382186 99382232 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 875 . 99382186 99382232 255,127,0
chr5 123096974 123097013 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 625 . 123096974 123097013 127,255,0
chr6 61914139 61914176 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 546 . 61914139 61914176 46,255,0
chr6 62284055 62284110 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 1000 . 62284055 62284110 255,0,0
chr7 45291604 45291662 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 990 . 45291604 45291662 255,10,0
chr7 61055755 61055807 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 695 . 61055755 61055807 198,255,0
chr7 145694445 145694509 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 877 . 145694445 145694509 255,125,0
chr7 158387938 158387974 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 555 . 158387938 158387974 56,255,0
chr7 159128585 159128630 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 534 . 159128585 159128630 34,255,0
chr8 43772274 43772317 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 597 . 43772274 43772317 98,255,0
chr8 68497700 68497739 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 613 . 68497700 68497739 115,255,0
chr9 42819101 42819158 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 652 . 42819101 42819158 155,255,0
chr9 66833155 66833209 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 573 . 66833155 66833209 74,255,0
chr9 66971107 66971261 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 565 . 66971107 66971261 66,255,0
chr9 67320735 67320897 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 604 . 67320735 67320897 106,255,0
chr9 70076722 70076776 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 627 . 70076722 70076776 129,255,0
chr9 70327463 70327519 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 622 . 70327463 70327519 124,255,0
chr9 72653114 72653161 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 604 . 72653114 72653161 106,255,0
chr9 78790132 78790181 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 570 . 78790132 78790181 71,255,0
chrUn_gl000225 196983 197030 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 603 . 196983 197030 105,255,0
chrX 55208088 55208129 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 736 . 55208088 55208129 240,255,0
chrX 55209943 55209979 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 516 . 55209943 55209979 16,255,0
chrX 61870838 61870881 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 535 . 61870838 61870881 35,255,0
chrX 125606486 125606523 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 584 . 125606486 125606523 85,255,0
chrY 4212831 4212882 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 1000 . 4212831 4212882 255,0,0
chrY 8979514 8979560 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 927 . 8979514 8979560 255,74,0
chrY 13704323 13704365 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 557 . 13704323 13704365 58,255,0
chrY 13868386 13868430 ID=SRX092302;Name=HDAC8%20(@%20K-562);Title=GSM777640:%20UChicago%20ChipSeq%20K562%20eGFP-HDAC8%20Control%20eGFP-HDAC8;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=UChicago;lab%20description=White%20-%20University%20of%20Chicago;data%20type=ChipSeq;data%20type%20description=ChIP-Seq;cell=K562;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20karyotype=cancer;cell%20lineage=mesoderm;cell%20sex=F;antibody=eGFP-HDAC8;antibody%20antibody%20description=Goat%20polyclonal;antibody%20target%20description=HDAC8;antibody%20vendor%20name=Kevin%20White;antibody%20vendor%20id=(None);control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control=Control_eGFP-HDAC8;control%20description=This%20data%20represents%20a%20control%20being%20compared%20to%20experiments%20using%20antibody%20eGFP-HDAC8;control%20id=K562/Input/Control_eGFP-HDAC8;replicate=1;replicate%20description=tier%201; 568 . 13868386 13868430 69,255,0